Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?
Isabel Conceição;
Med Clin. 2024;162:e70-3
Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy
Maria Antonia Ribot Sanso; Adrián Rodriguez Rodriguez; Laura Martínez Vicente; Teresa Sevilla; Cristina Borrachero Garro; Julian Fernández Martín; Adrián Antón Vicente; Moises Morales de la Prida; Lucía Galán Dávila; Laura González Vázquez; Ferran Martínez Valle; Carlos Casasnovas Pons; Arturo Fraga Bau; Eugenia Cisneros Barroso; Inés Losada López; Juan González-Moreno;
Med Clin. 2024;162:e27-32
Follow-up regimens for carriers of hereditary transthyretin variants
Inés Asunción Losada-López; Solange Kapetanovic-García; Teresa Sevilla-Mantecón; Francisco Muñoz-Beamud;
Med Clin. 2023;160:213-7